For instance, signaling through BAFF (B-cell activating factor) and APRIL (a proliferation-inducing ligand), whose levels are increased in MM patients compared to healthy controls, induces expression of both MCL-1 and BCL-2 and promotes PC survival (24, 76). This evidence concerns the gene MCL1 and Miyoshi myopathy.